ICON Public Limited Company (ICLR) Stock

ICON Public Limited Company (ICLR) is a Technology stock trading at $145.90 (as of 2026-06-18), with a market capitalization of $10.42B and a trailing P/E of 50.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

ICON Public Limited Company provides outsourced clinical development services, including program management and related research and analytics activities, supporting different stages of clinical trials. It serves pharmaceutical, biotechnology, and medical device customers across Ireland, other European markets, the United States, and internationally.

Valuation — source: SEC EDGAR (first-party)
Price$145.90
Market Cap$10.42B
P/E Ratio50.3
EV / EBITDA16.2
Price / Book1.22
Price / Sales1.35
DCF Value (model)$155.39
DCF Upside vs Price6.5%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$8.25B
Net Margin2.8%
Return on Equity2.5%
Debt / Equity0.31
Current Ratio1.10
Revenue Growth (YoY)-0.4%
EPS Growth (YoY)-69.6%
FCF Growth (YoY)-22.9%
Financial Health — source: SEC EDGAR
Altman Z-Score1.75 (distress)
Valuation vs Sector & Industry
Stock P/E50.3
Sector P/E (Technology)32.6
Industry P/E (Business Services)27.1
vs Sector54.2%
vs Industry85.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderArtisan Partners Limited Partnership ($916.15M)
Institutional Holders Tracked10
Company
SectorTechnology
IndustryBusiness Services
CEOBarry Balfe
Employees41,250
CountryIE
IPO Date1998-05-15

Related Companies (Business model: Clinical Labs / CRO Services; 8 closest by market cap; US-domiciled)

  • Natera, Inc. (NTRA)
  • Labcorp Holdings Inc. (LH)
  • Quest Diagnostics Incorporated (DGX)
  • Medpace Holdings, Inc. (MEDP)
  • Guardant Health, Inc. (GH)
  • Charles River Laboratories International, Inc. (CRL)
  • Repligen Corporation (RGEN)
  • Caris Life Sciences, Inc. (CAI)
ICLR earnings history · ICLR institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.